NMPA unveils plan to bring AI into drug regulation
Subscribe to keep reading.
Trivium Tech keeps you briefed on the latest developments in China tech policy.
Already a subscriber? Log in.
What happened: On April 2, the National Medical Products Administration (NMPA) released guidelines on integrating AI into pharmaceutical regulation.
This initiative is part of Beijing's broader "AI Plus" plan, which aims to incorporate AI more deeply into all areas of society, including governance....